← back to search

Catherine Koch

Massachusetts Institute of Technology · US
Area of research
Equine · Cell Biology
Research interest
Research interests include Biology, Cancer research, Cell biology, Oxaliplatin, Cisplatin, and Carboplatin.
h-index
citations
953
works
6
NIH funding
primary concept
email

Recent publications

Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening
Nature Communications 2023cited by 24position: middledoi
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
Nature Biomedical Engineering 2022cited by 64position: middledoi
Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration
Disease Models & Mechanisms 2020cited by 39position: middledoi
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Nature Medicine 2017cited by 521position: middledoi
Amphiphysin 2 Orchestrates Nucleus Positioning and Shape by Linking the Nuclear Envelope to the Actin and Microtubule Cytoskeleton
Developmental Cell 2015cited by 72position: middledoi
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
Nature Genetics 2012cited by 233position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael T. Hemann · Massachusetts Institute of Technology3 papers (2017–2023)Taeyoon Kyung · Massachusetts Institute of Technology2 papers (2022–2023)Vincent Gache · Université Claude Bernard Lyon 12 papers (2015–2020)Jocelyn Laporte · Centre National de la Recherche Scientifique2 papers (2015–2020)Azucena Ramos · Massachusetts Institute of Technology2 papers (2022–2023)Michael E. Birnbaum · Ragon Institute of MGH, MIT and Harvard2 papers (2022–2023)Khloe S. Gordon · Massachusetts Institute of Technology2 papers (2022–2023)Christos Gavriilidis · Newcastle University2 papers (2015–2020)Amanda Hutchins · Yale University1 papers (2012–2012)Jan E. Carette · Stanford Medicine1 papers (2012–2012) · 1 papers (2020–2020)John G. Doench · Broad Institute1 papers (2023–2023)Richard Possemato · NYU Langone’s Laura and Isaac Perlmutter Cancer Center1 papers (2012–2012)Clary B. Clish · Broad Institute1 papers (2012–2012) · 1 papers (2020–2020)Douglas A. Lauffenburger · Ragon Institute of MGH, MIT and Harvard1 papers (2022–2022)Timothy J. Eisen · Vanderbilt University1 papers (2017–2017)Alina Starchenko · BioNTech (United States)1 papers (2022–2022)Belinda S. Cowling · Monash University1 papers (2020–2020)Rebecca C. Larson · Broad Institute1 papers (2023–2023)